The global Feed Grade Chlortetracycline and Chlortetracycline HCL market size is predicted to grow from US$ 206 million in 2025 to US$ 269 million in 2032; it is expected to grow at a CAGR of 3.9% from 2026 to 2032.

In 2025, global Feed Grade Chlortetracycline and Chlortetracycline HCL production reached approximately 74 k tons, with an average global market price of around US$ per . Feed grade chlortetracycline is a veterinary antibiotic mainly used in animal feed. It is a tetracycline class antibiotic produced through the fermentation of Streptomyces aureofaciens. It plays a crucial role in the livestock industry, aiming to prevent and treat certain diseases in animals and also promote their growth. Chlortetracycline HCL is the hydrochloride form of chlortetracycline and is a tetracycline class antibiotic. It is prepared through a chemical synthesis method based on chlortetracycline and has stronger water - solubility, which is more convenient for applications in the fields of medicine and veterinary medicine.

The global market for feed-grade chlortetracycline and chlortetracycline HCl is highly concentrated, with Chinas Jinhe Biological and Zhengda Biological collectively holding over 90% of global production capacity. Jinhe Biological has an annual comprehensive capacity of about 55,000 tons, making it the worlds largest production base, while Zhengda Biological has an annual capacity of approximately 28,000 tons. Driven by the scale of the breeding industry, Jinhes 2025 interim report showed simultaneous growth in domestic and international sales of chlortetracycline, with particularly strong performance in overseas markets. Development trends include ongoing capacity expansion (e.g., Jinhes Phase VI project), broadening application scenarios (e.g., new approval for use in lambs), and volume-price increases in overseas markets. Opportunities arise from the intensification of global breeding, growing demand in emerging markets, and new applications in ruminants. However, significant obstacles exist, such as potential high tariff barriers from Sino-US trade frictions, policy restrictions due to antibiotic resistance concerns, and raw material price volatility.

Infinity Market Research newest research report, the Feed Grade Chlortetracycline and Chlortetracycline HCL Industry Forecast looks at past sales and reviews total world Feed Grade Chlortetracycline and Chlortetracycline HCL sales in 2025, providing a comprehensive analysis by region and market sector of projected Feed Grade Chlortetracycline and Chlortetracycline HCL sales for 2026 through 2032. With Feed Grade Chlortetracycline and Chlortetracycline HCL sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Feed Grade Chlortetracycline and Chlortetracycline HCL industry.

This Insight Report provides a comprehensive analysis of the global Feed Grade Chlortetracycline and Chlortetracycline HCL landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Feed Grade Chlortetracycline and Chlortetracycline HCL portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Feed Grade Chlortetracycline and Chlortetracycline HCL market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Feed Grade Chlortetracycline and Chlortetracycline HCL and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Feed Grade Chlortetracycline and Chlortetracycline HCL.

This report presents a comprehensive overview, market shares, and growth opportunities of Feed Grade Chlortetracycline and Chlortetracycline HCL market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    Feed Grade Chlortetracycline
    Chlortetracycline Hydrochloride
    Segmentation by Regulatory Status:
    Prescription
    Non-prescription
    Segmentation by Grade:
    Feed Grade
    Veterinary Drug Grade

Segmentation by Application:

    Pig
    Poultry
    Cattle & Sheep
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    Jinhe Biotechnology
    Chia Tai Enterprises International
    Fujian Fukang Pharmaceutical
    Zoetis
    Univet

Key Questions Addressed in this Report

What is the 10-year outlook for the global Feed Grade Chlortetracycline and Chlortetracycline HCL market?
What factors are driving Feed Grade Chlortetracycline and Chlortetracycline HCL market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Feed Grade Chlortetracycline and Chlortetracycline HCL market opportunities vary by end market size?
How does Feed Grade Chlortetracycline and Chlortetracycline HCL break out by Type, by Application?